Dipyridamole’s beneficial effects in treating several eye disorders (dry eye, pterygium, pinguecula, viral eye infection, blepharitis, eye inflammation, cataract, nevus and conjunctival melanoma) were discovered by Moshe Rogosnitzky.

Moshe Rogosnitzky is the Director of the Center for Drug Repurposing at Ariel University and Co-Founder and Director of Research of the nonprofit MedInsight^® Research Institute. For over 15 years Moshe has directed Adjuvant Medical Solutions - a personalized medicine consultancy. He has spent his career advancing the field of personalized medicine and successfully innovating new uses for existing drugs. His discoveries have benefited hundreds of thousands of patients, and his scholarly publications span a wide range of subjects including: liver, pancreatic, breast and prostate cancers, Crohn’s disease, eye disorders, gastrointestinal and abdominal surgeries, and hemostasis.

More details about Moshe Rogosnitzky: